NCT06898489

Brief Summary

The goal of this observational study is to investigate the long-term adjunctive effects of Traditional Chinese Five-Tone Therapy (Yu Tone) in patients with systemic lupus erythematosus (SLE). The main question it aims to answer is: Does Yu-tone music therapy improve psychological well-being and quality of life in SLE patients when used as a complementary intervention alongside standard pharmacotherapy? Participants already receiving Yu-tone music therapy as part of their integrative care for SLE will complete validated online questionnaires assessing psychological distress (e.g., anxiety, depression), disease-related quality of life, and medication adherence monthly for 2 years.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Mar 2025Jan 2027

Study Start

First participant enrolled

March 1, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

March 21, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 27, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

March 27, 2025

Status Verified

March 1, 2025

Enrollment Period

1.6 years

First QC Date

March 21, 2025

Last Update Submit

March 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • SLEDAI score

    From enrollment to the treatment at 12 weeks

Study Arms (2)

Control group

No Yu-tone music intervention, receiving conventional pharmacotherapy only.

Drug: Conventional pharmacotherapy

Yu-Tone Music Intervention Group

In addition to conventional pharmacotherapy, SLE patients receive a structured Yu-tone music listening program

Combination Product: Yu-Tone Music InterventionDrug: Conventional pharmacotherapy

Interventions

Yu-Tone Music InterventionCOMBINATION_PRODUCT

SLE patients undergo a structured Yu-tone music listening program (30 minutes daily, 5 days per week, with each cycle lasting 8 weeks, for a total of 3 cycles

Yu-Tone Music Intervention Group

Standard SLE medications (e.g., hydroxychloroquine, glucocorticoids).

Control groupYu-Tone Music Intervention Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study Population are Chinese

You may qualify if:

  • Meet the 2019 ACR/EULAR classification criteria for SLE; ② Adults aged 18 years or older; ③ Provide informed consent to participate in the study.

You may not qualify if:

  • Presence of severe organ dysfunction (e.g., renal failure, cardiac insufficiency) or psychiatric disorders; ② Diagnosed with hearing impairment or auditory disorders; ③ Inability to comprehend or complete study questionnaires (e.g., due to cognitive impairment or language barriers).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hangzhou, 310053, China.

Hangzhou, China

Location

MeSH Terms

Conditions

Lupus Erythematosus, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD Candidate

Study Record Dates

First Submitted

March 21, 2025

First Posted

March 27, 2025

Study Start

March 1, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

March 27, 2025

Record last verified: 2025-03

Locations